How the tectorial membrane in the inner ear helps us hear
Experimental Theoretical Studies of Cochlear Mechanisms
This project looks at how the gel-like layer inside the cochlea shapes hearing and how changes in it may cause hearing loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11231712 on NIH RePORTER |
What this research studies
You will be hearing about research that focuses on the tectorial membrane, a gel-rich part of the inner ear that helps determine sensitivity to sound and how sharply the ear distinguishes frequencies. Scientists measure the membrane's mechanical behavior using tiny probes (atomic force microscopy) and study how water moving through the gel-like matrix affects timing of responses. They combine laboratory measurements on tissue samples and physical models to describe the membrane's poroelastic (gel plus fluid) properties. The work also examines how genetic mutations or cochlear damage change these properties, which could inform future diagnostics or device designs.
Who could benefit from this research
Good fit: People with sensorineural hearing loss, inherited cochlear membrane disorders, or individuals considering cochlear implants are the most relevant patient groups for this research.
Not a fit: Those whose hearing problems are due to middle-ear disease, auditory nerve loss, or unrelated balance disorders are less likely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this work could lead to better ways to diagnose certain types of hearing loss and guide improvements in treatments or cochlear implant design.
How similar studies have performed: Previous laboratory studies have suggested the tectorial membrane’s gel-like behavior affects frequency selectivity, but applying poroelastic measurements and models to this problem is relatively new.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Freeman, Dennis M — Massachusetts Institute of Technology
- Study coordinator: Freeman, Dennis M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.